LLLingli Li

Lingli Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lingli Li has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher Stuart Wilcox

    Division of Nephrology and Hypertension and Hypertension Research Center, Georgetown University, Washington, D.C.

    2 shared publications
  • En Yin Lai

    From the Division of Nephrology and Hypertension, and Hypertension Research Center, Georgetown University, Washington, DC (L.L., E.Y.L., Z.L., G.S., M.M., W.J.W., C.S.W.)

    2 shared publications
  • Glenn Solis

    From the Division of Nephrology and Hypertension, and Hypertension Research Center, Georgetown University, Washington, DC (L.L., E.Y.L., Z.L., G.S., M.M., W.J.W., C.S.W.)

    2 shared publications
  • Kathy K. Griendling

    Emory University School of Medicine

    2 shared publications
  • William J. Welch

    Department of Statistics University of British Columbia V6T 1Z4 Vancouver BC Canada

    2 shared publications
  • Zaiming Luo

    From the Division of Nephrology and Hypertension, and Hypertension Research Center, Georgetown University, Washington, DC (L.L., E.Y.L., Z.L., G.S., M.M., W.J.W., C.S.W.)

    2 shared publications

Latest Publications

  • Di'ao Xinxuekang: Therapeutic Potential in Cardiovascular Diseases

    by Shengyu Zhang, Lingli Li, Mingying Deng, Yanan Wang, AiZong Shen, Lei Zhang

    Background: Cardiovascular disease is the leading cause of death in both developed and developing countries. Di'ao Xinxuekang (DAXXK) is a pure Chinese medicine herbal preparation refined from dioscin extracted from the roots of Dioscorea panthaica Prain et Burk and Diosorea nipponica Makino. Objective: To evaluate the application of DAXXK in Cardiovascular disease. Methods: : We searched and summarized all the studies on DAXXK and Cardiovascular disease in pumend, Google, and CNKI. Results: Modern pharmacological studies have shown that DAXXK has pharmacological effects such as dilating blood vessels, lowering blood pressure and cardiac load, improving hemodynamics, lowering blood lipids and anti-platelet aggregation, and is widely used for the therapy of various kinds of cardiovascular diseases, including hypertension, atherosclerosis, coronary heart disease (CHD), angina pectoris (AP) and myocardial infarction. We provide an overview of the clinical efficacy, molecular mechanisms, safety and therapeutic potential of DAXXK in the treatment of cardiovascular disease, aiming to provide clues and evidence for clinical decision-making. Conclusion: DAXXK exerts cardiovascular protection by regulating a variety of cardiovascular disease-related signaling pathways.


  • The construction of high precision geostrophic currents based on new gravity models of GOCE and satellite altimetry data

    by Wenyan Sui, Junru Guo, Jun Song, Zhiliang Liu, Meng Wang, Xibin Li, Yanzhao Fu, Yongquan Li, Yu Cai, Linhui Wang, et al.


  • Open Access

    High Salt Enhances Reactive Oxygen Species and Angiotensin II Contractions of Glomerular Afferent Arterioles From Mice With Reduced Renal Mass

    by Lingli Li, En Yin Lai, Zaiming Luo, Glenn Solis, Margarida Mendonca, Kathy K. Griendling, Anton Wellstein, William J. Welch, Christopher S. Wilcox

    High salt, Ang II (angiotensin II), and reactive oxygen species enhance progression of chronic kidney disease. We tested the hypothesis that a high salt intake generates specific reactive oxygen species to enhance Ang II contractions of afferent arterioles from mice with reduced renal mass (RRM). C57BL/6 mice were subjected to surgical RRM or sham operations and received 6% or 0.4% NaCl salt diet for 3 months. Ang II contractions were measured in perfused afferent arterioles and superoxide (O 2 − ) and hydrogen peroxide (H 2 O 2 ) by fluorescence microscopy. RRM enhanced the afferent arteriolar gene expression for p47 phox and neutrophil oxidase (NOX) 2 and high salt intake in RRM mice enhanced gene expression for angiotensin type 1 receptors, POLDIP2 and NOX4 and reduced catalase. High salt in mice with RRM enhanced arteriolar O 2 − and H 2 O 2 generation and maximal contractions to Ang II (10 –6 mol/L) that were dependent on O 2 − because they were prevented by gene deletion of p47 phox and on H 2 O 2 because they were prevented by transgenic smooth muscle cell expression of catalase (tg CAT-SMC ) and POLDIP2 gene deletion. Three months of tempol normalized arteriolar reactive oxygen species and Ang II contractions. However, arteriolar contractions to lower concentrations of Ang II (10 –8 to 10 –11 mol/L) were paradoxically inhibited by H 2 O 2 and POLDIP2. In conclusion, both O 2 − from p47 phox /NOX2 and H 2 O 2 from NOX4/POLDIP2 enhance maximal arteriolar Ang II contractions from RRM mice during high salt, but H 2 O 2 and NOX4/POLDIP2 reduce the sensitivity to lower concentrations of Ang II by >100-fold. Tempol prevents all of these changes in function.


  • Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease

    by Lingli Li, En Yin Lai, Zaiming Luo, Glenn Solis, Kathy K. Griendling, W. Robert Taylor, Pedro A. Jose, Anton Wellsten, William J. Welch, Christopher S. Wilcox